Depressive Disorder, Treatment-Resistant
-
Subject Areas on Research
- A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials.
- A double-blind pilot dosing study of low field magnetic stimulation (LFMS) for treatment-resistant depression (TRD).
- A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study).
- A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder.
- Adjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale.
- Can psychological features predict antidepressant response to rTMS? A Discovery-Replication approach.
- Chronic Vagus Nerve Stimulation Significantly Improves Quality of Life in Treatment-Resistant Major Depression.
- Clinical Experience With High-Dosage Pramipexole in Patients With Treatment-Resistant Depressive Episodes in Unipolar and Bipolar Depression.
- Clinically meaningful changes on depressive symptom measures and patient-reported outcomes in patients with treatment-resistant depression.
- Combination of lithium and electroconvulsive therapy (ECT) is associated with higher odds of delirium and cognitive problems in a large national sample across the United States.
- Comparison of academic and nonacademic sites in multi-center clinical trials.
- Difficult-to-treat depression: A clinical and research roadmap for when remission is elusive.
- Does change in ECT electrode placement help temporomandibular joint pain?
- Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression-TRANSFORM-3.
- Electroconvulsive therapy device classification: response to FDA advisory panel hearing and recommendations.
- High-frequency repetitive TMS for suicidal ideation in adolescents with depression.
- Improvement in quality of life with left prefrontal transcranial magnetic stimulation in patients with pharmacoresistant major depression: acute and six month outcomes.
- Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression.
- Increased hippocampal tail volume predicts depression status and remission to anti-depressant medications in major depression.
- Ketamine for treatment-resistant depression: ready or not for clinical use?
- Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression.
- Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants.
- Metabolomic signatures of intravenous racemic ketamine associated remission in treatment-resistant depression: A pilot hypothesis generating study.
- Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: A pilot randomised controlled trial.
- Prediction of nonremission to antidepressant therapy using diffusion tensor imaging.
- Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
- Prevalence of obstructive sleep apnea in suicidal patients with major depressive disorder.
- Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression.
- Reconceptualising treatment-resistant depression as difficult-to-treat depression.
- Relationship between obesity and depression: characteristics and treatment outcomes with antidepressant medication.
- Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.
- Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial.
- The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF).
- The identification, assessment and management of difficult-to-treat depression: An international consensus statement.
- Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects.